Services

1. Sterile Dosage Forms 2/22/2012

   DSM manufactures sterile dosage form pharmaceuticals, comprising aseptic liquid filling, cytotoxic formulation and filling, and lyophilization.

2. Lyophilization / Potent And Cytotoxic Compounds 1/28/2014

   As a first adopter of new international cross-containment guidelines recommended by ISPE (Risk-MaPP), OsoBio expertly manages the risks posed by potent and cytotoxic compounds and DEA scheduled substances, successfully balancing the need for product quality and operator safety.

3. Fill & Finish / Late-Phase And Commercial Pharmaceutical Manufacturing 1/28/2014

   OsoBio is committed to serving as your contract manufacturing organization (CMO) of choice for late-phase clinical trials and bringing them to commercialization – especially those that involve biologic, highly potent or controlled compounds.

4. Lyophilization / Late-Phase And Commercial Pharmaceutical Manufacturing 1/28/2014

   OsoBio is committed to serving as your contract manufacturing organization (CMO) of choice for late-phase clinical trials and bringing them to commercialization – especially those that involve biologic, highly potent or controlled compounds.

5. Fill & Finish / Potent And Cytotoxic Compounds 1/28/2014

   As a first adopter of new international cross-containment guidelines recommended by ISPE (Risk-MaPP), OsoBio expertly manages the risks posed by potent and cytotoxic compounds and DEA scheduled substances, successfully balancing the need for product quality and operator safety.

6. Fill & Finish / Clinical Trials Manufacturing 1/28/2014

   OsoBio offers significant knowledge and experience in late-phase clinical products and successfully taking them to commercialization. In the history of our Albuquerque, N.M., facility, OsoBio has manufactured more than 250 distinct commercial presentations in every major therapeutic category.

7. Lyophilization / Clinical Trials Manufacturing 1/28/2014

   OsoBio offers significant knowledge and experience in late-phase clinical products and successfully taking them to commercialization. In the history of our Albuquerque, N.M., facility, OsoBio has manufactured more than 250 distinct commercial presentations in every major therapeutic category.

8. Clinical Trial Manufacturing 1/3/2014

   OsoBio offers significant knowledge and experience in late-phase clinical products and successfully taking them to commercialization. In the history of our Albuquerque, N.M., facility, OsoBio has manufactured more than 250 distinct commercial presentations in every major therapeutic category.

9. Potent And Cytotoxic Compounds 1/3/2014

   As a first adopter of new international cross-containment guidelines recommended by ISPE (Risk-MaPP), OsoBio expertly manages the risks posed by potent and cytotoxic compounds and DEA scheduled substances, successfully balancing the need for product quality and operator safety.

10. Late-Phase And Commercial Pharmaceutical Manufacturing 1/3/2014

    OsoBio is committed to serving as your contract manufacturing organization (CMO) of choice for late-phase clinical trials and bringing them to commercialization – especially those that involve biologic, highly potent or controlled compounds.